No Data
This Thursday marks the start of the "soul negotiation" for medical insurance. Which companies are likely to be selected?
According to the National Medical Insurance Administration, a press conference will be held at 10 a.m. on November 28 at the National Medical Insurance Administration to announce the adjustments to the national medical insurance pharmaceutical catalog for 2024 and answer questions from reporters. This means that the results of the national negotiation for medical insurance centralized purchasing in 2024 will be announced this Thursday.
Many innovative drugs stocks in Hong Kong suddenly soared!
On the morning of November 25, the hang seng index fell slightly, while the Hong Kong stock market's biomedical sector performed well. Notably, several biomedical companies saw their stock prices rise significantly due to recent news of major collaboration advancements.
Jiangsu Recbio Technology to Issue Up to 800 Million Yuan of Shares to Pharmaceutical Company
Richcore Bio (02149.HK) issued 0.143 billion shares of domestic shares, with a subscription price of 5.59 RMB per share.
Recko Bio-B (02149.HK) announced that the board of directors approved the proposal to issue domestic shares at a targeted price at yesterday's (11th) meeting, planning to issue up to 0.143 billion domestic shares to subscribers based on special authorization. In addition, Recko Bio signed a share subscription contract with Yangtze River Pharmaceutical Group yesterday. It is reported that Yangtze River Pharmaceutical Group conditionally agreed to subscribe to a total of 0.143 billion domestic shares issued by Recko Bio, at a subscription price of RMB 5.59 per share. (js/w)~
Ruikang Biology-B (02179) plans to issue up to 0.143 billion shares of domestic stock to Yangtze River Pharmaceutical Group based on special authorization.
Ruikesheng Biology-B (02179) issued an announcement to further enhance the company's overall competitiveness and increase risk resilience,...
Jiangsu Recbio Technology Initiates Phase III Clinical Trials for Shingles Vaccine
